Tacrolimus News and Research

RSS
Tacrolimus is a drug used to help reduce the risk of rejection by the body of organ and bone marrow transplants.
3SBio and Isotechnika enter strategic agreement for voclosporin in China

3SBio and Isotechnika enter strategic agreement for voclosporin in China

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

FDA grants LifeCycle Pharma SPA for LCP-Tacro pivotal Phase 3 study in 'de novo' kidney transplant patients

Limerick to announce new results from LIM-0705 human trials at 23rd Transplantation Society congress

Limerick to announce new results from LIM-0705 human trials at 23rd Transplantation Society congress

Astellas extends non-exclusive license agreement with Regeneron for VelocImmune technology

Astellas extends non-exclusive license agreement with Regeneron for VelocImmune technology

Seattle Genetics, Agensys commence ASG-5ME ADC phase I clinical trial for metastatic pancreatic cancer

Seattle Genetics, Agensys commence ASG-5ME ADC phase I clinical trial for metastatic pancreatic cancer

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

FDA accepts to review sNDA for SPRYCEL for treating adult patients with CML

Watson Laboratories receives FDA approval for Tacrolimus ANDA

Watson Laboratories receives FDA approval for Tacrolimus ANDA

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Cyclosporine treatment develops higher de novo cancer risk in liver transplant patients: Researchers

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Merck proposes to initiate Phase II proof-of-concept clinical study of posaconazole for chronic Chagas disease

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Four-year follow-up results from SPRYCEL Phase 3 study in CML-CP presented at ASCO

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Dr. Reddy's Laboratories launches tacrolimus capsules in the US market

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Belatacept preserves kidney function in transplant recipients better than cyclosporine, says study

Seattle Genetics, Agensys present ASG-5ME ADC preclinical data at 101st AACR

Seattle Genetics, Agensys present ASG-5ME ADC preclinical data at 101st AACR

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Isotechnika Pharma releases fourth quarter financial results; reviews operational and scientific highlights for 2009

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

Positive results from Limerick BioPharma's LIM-0705 Phase 1a trial

KAPIDEX to be marketed as DEXILANT in the U.S.

KAPIDEX to be marketed as DEXILANT in the U.S.

Belatacept drug can prevent graft rejection in kidney transplant recipients

Belatacept drug can prevent graft rejection in kidney transplant recipients

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Overview of Psoriasis

Overview of Psoriasis

Bortezomib can improve control of GVHD and immune system recovery

Bortezomib can improve control of GVHD and immune system recovery